Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Public Notice on the Completion and Commissioning of Environmental Protection Facilities for the 980-Ton Per Year Norfloxacin Technology Upgrade Project (Front-End Supplement) at Wanbangde Pharmaceutical Group Co., Ltd.

Date:

18 Nov,2022


Previous page

Good News! Wanbangde Pharmaceutical Group has been named to the "Most Promising Growth Enterprise in China's Pharmaceutical Industry" list for the fourth consecutive year!

Quality Month | Wanbande Pharmaceutical Group’s 5th Annual QCC Selection Event Concludes Successfully

Next page

Related Recommendations

Image Name

2021/03/01

Vice Mayor Jiang Bingfeng of Taizhou City Visits Wanbangde Group for Inspection

Image Name

2021/03/01

Chen Yijun, Secretary of the Taizhou Municipal Party Committee, visited Wanbangde Group and encouraged the company to "take root in their hometown, focus on developing real industries, and leverage industry growth to drive the company's high-quality, sustainable development!"

Image Name

2021/03/01

Wanbangde Pharmaceutical Group Holds the Launching Ceremony for Its Second "Quality Month" Campaign

< 1...484950...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38